MAIA Biotechnology, Inc. (MAIA) is a publicly traded Healthcare sector company. As of May 21, 2026, MAIA trades at $1.29 with a market cap of $76.61M and a P/E ratio of -1.82. MAIA moved +3.66% today. Year to date, MAIA is -14.57%; over the trailing twelve months it is -29.12%. Its 52-week range spans $0.87 to $3.48. Analyst consensus is buy with an average price target of $14.00. Rallies surfaces MAIA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
MAIA Biotechnology, Inc. (MAIA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. MAIA moved +3.66% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $1.29 |
| Market Cap | $76.61M |
| P/E Ratio | -1.82 |
| EPS | $-0.70 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.48 |
| 52-Week Low | $0.87 |
| Volume | 448.00K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-22.40M |
| Gross Margin | 0.00% |
1 analysts cover MAIA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.00.